Quiet Eye Duration in Baseball

March 6, 2024 updated by: Nicklaus Fogt, Ohio State University
The purpose of this study is to measure the gaze movements of individuals as they watch videos of a baseball pitcher throwing pitches. The goal will be to determine whether there is an anticipatory movement to the location where the ball is released, and whether this anticipatory movement occurs in experienced baseball players more commonly than in inexperienced players.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

20 subjects between 18 and 40 years of age (males and females) will participate. 10 subjects will be required to have experience in baseball or softball at the high school level or above within the last 10 years. A further 10 subjects will be recruited who did not have baseball experience at or above the high school level. Upon entering the laboratory, the experiment will be explained to the subjects. Subjects will be consented. Then, the subject's visual acuity and stereoacuity (depth perception) will be measured.

If subjects continue on to the experiment, they will also be asked to complete a short survey on previous baseball experience.

Subjects will stand in a batting stance facing a projector screen. They will then participate in trials in which they mimic batting a ball thrown by a pitcher. Six different pitch videos will be shown. The subjects will act as if they are batting the ball (no bat swing will occur) for each video. The movement of the subject's eye will be tracked using an eye tracker.

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Nick F Fogt, OD, PhD
  • Phone Number: 6146884594 614-688-4594
  • Email: fogt.4@osu.edu

Study Locations

    • Ohio
      • Columbus, Ohio, United States, 43210
        • The Ohio State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 20/20 visual acuity in each eye Stereoacuity of 40 arc seconds are better

Exclusion Criteria:

  • 20/25 or worse visual acuity in either eye Stereoacuity less than 40 arc seconds

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Gaze tracking
No intervention. Monitor gaze as subjects watch a video
Monitor gaze as subjects watch a video

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quiet eye duration
Time Frame: 60 minutes
Duration over which the gaze remains stable
60 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nick F Fogt, Ohio State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 5, 2022

Primary Completion (Actual)

September 15, 2023

Study Completion (Estimated)

July 31, 2024

Study Registration Dates

First Submitted

February 26, 2020

First Submitted That Met QC Criteria

February 26, 2020

First Posted (Actual)

February 28, 2020

Study Record Updates

Last Update Posted (Actual)

March 7, 2024

Last Update Submitted That Met QC Criteria

March 6, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2019H0403

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gaze Tracking

Clinical Trials on Gaze tracking - no intervention

3
Subscribe